Stocks TelegraphStocks Telegraph
Stock Ideas

ALC Company Profile and Key Details

NYSE : ALC

Alcon

$78.44
-0.39-0.49%
At Close 4:00 PM
50
BESG ScoreESG Rating

Price Chart

Stock Price Today

Alcon Inc. (ALC) stock declined over -0.49%, trading at $78.44 on NYSE, down from the previous close of $78.83. The stock opened at $79.07, fluctuating between $78.00 and $79.07 in the recent session.

Stock Snapshot

78.83
Prev. Close
38.8B
Market Cap
77.995
Day Low
37.35
P/E Ratio
2.1
EPS (TTM)
1.08
Cash Flow per Share
79.07
Open
494.6M
Number of Shares
79.07
Day High
99.78%
Free Float in %
41.8
Book Value
1.26M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 09, 202679.0779.1078.0478.441.38M
Feb 06, 202677.4478.8977.4478.832.09M
Feb 05, 202678.2779.1678.0678.372.94M
Feb 04, 202678.6679.6778.4379.063.04M
Feb 03, 202678.0178.7576.9577.332.23M
Feb 02, 202679.6580.1579.1579.381.45M
Jan 30, 202681.5881.9380.6480.981.02M
Jan 29, 202681.1981.3680.1581.151.38M
Jan 28, 202680.1180.6379.8180.421.08M
Jan 27, 202680.6481.0680.4580.871.02M
Jan 26, 202680.7681.4280.6980.79637.36K
Jan 23, 202680.4380.5079.5880.29853.32K
Jan 22, 202680.9382.1480.9181.021.02M
Jan 21, 202680.8881.9780.7681.622.83M
Jan 20, 202678.6179.8878.2779.061.87M
Jan 16, 202680.2080.2078.9679.001.43M
Jan 15, 202679.5879.7178.7879.671.12M
Jan 14, 202679.6480.2778.9780.111.25M
Jan 13, 202681.2681.5677.8978.991.94M
Jan 12, 202681.2181.6580.5080.861M

Contact Details

Geneva, 1214

Switzerland

https://www.alcon.com415 891 12000

About Company

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Company Information

Employees25599
Beta0.69
Sales or Revenue$10.09B
5Y Sales Change%0.31%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Instruments & Supplies

Company Overview

Alcon Inc. (NYSE:ALC) closed at $78.44 USD, losing -$0.39 (-0.49%) from the previous close of $78.83. The stock is currently mid-range between its 52-week high and low $71.55 and $99.20. With a market capitalization of about $38.80 billion, Alcon Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.69). Key stats such as the average daily volume over the past year has been around 1.63 million shares, in line with its 52-week average. Headquartered in Geneva, None, Alcon Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO David J. Endicott, the company employs approximately 25,599 people and listed since April 09, 2019. Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -1.72%, SMA50 -1.6%, SMA200 -4.76%). The stock’s 14-day RSI is 44.92 (neutral), while the ATR of 1.52 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -20.93% below its high and over 9.63% above its low. Average 10-day trading volume of 2.02 million shares is slightly above the 3-month average of 1.63 million, indicating heightened recent market interest.

Dividend & Fair Value

Alcon Inc. last paid a dividend of 0.33 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $31.99. This means the shares are trading above this model’s fair value.

Frequently Asked Questions

What is the current Alcon Inc. (ALC) stock price?
Alcon Inc. (NYSE: ALC) stock price is $78.44 in the last trading session. During the trading session, ALC stock reached the peak price of $79.07 while $78.00 was the lowest point it dropped to. The percentage change in ALC stock occurred in the recent session was -0.49% while the dollar amount for the price change in ALC stock was - $0.39.
ALC's industry and sector of operation?
The NYSE listed ALC is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Alcon Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ALC?
Mr. David J. Endicott
Chief Executive Officer & Director
Mr. Arthur B. Cummings M.D.
Executive Director
Mr. Royce R. Bedward
Senior Vice President, Gen. Counsel & Corporation Sec.
Mr. F. Michael Ball
Executive Chairman
Ms. Kimberly Martin
Senior Vice President & Chief HR Officer
Mr. Timothy C. Stonesifer
Chief Financial Officer
Ms. Sue-Jean Lin
Senior Vice President & Chief Information and Transformation Officer
Margaret Buckley
Chief Accounting Officer
Dr. Franck Leveiller
Senior Vice President, Head of Global R&D and Chief Scientific Officer
Mr. Laurent Attias
Head of Corporation Devel., Strategy, BD&L and M&A
How ALC did perform over past 52-week?
ALC's closing price is 9.63% higher than its 52-week low of $71.55 where as its distance from 52-week high of $99.20 is -20.93%.
How many employees does ALC have?
Number of ALC employees currently stands at 25,599.
Link for ALC official website?
Official Website of ALC is: https://www.alcon.com
How do I contact ALC?
ALC could be contacted at phone 415 891 12000 and can also be accessed through its website. ALC operates from Chemin de Blandonnet 8, Geneva, 1214, Switzerland.
How many shares of ALC are traded daily?
ALC stock volume for the day was 1.26M shares. The average number of ALC shares traded daily for last 3 months was 1.63M.
What is the market cap of ALC currently?
The market value of ALC currently stands at $38.80B with its latest stock price at $78.44 and 494.6M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph